TMates vs Telos Rx: Flat Pricing vs Lower Starting Cost
Looking for a direct comparison of TMates vs Telos Rx? Quick verdict: TMates emphasizes a flat $199/month model, 24/7 U.S. doctor access, and same price at every dose; Telos Rx emphasizes lower starting prices with semaglutide as low as $99/month and tirzepatide as low as $139/month, if a licensed provider approves you.
Start TMates semaglutide program
Top differences at a glance for TMates vs Telos Rx
This comparison focuses on the most distinctive differences supported by the sources: pricing model and starting cost, medication options, clinician access and oversight, state coverage and shipment, and the regulatory status of compounded drugs. Each point compares TMates and Telos Rx directly using only supplied facts.
1. Pricing model and starting cost
TMates: TMates advertises a flat $199/month price “at every dose” with the source repeating “$199/month, every dose, no step-up fees” and noting tiered amounts for multi month bundles. Telos Rx: Telos lists semaglutide “as low as $99 per month” and tirzepatide “as low as $139 per month,” with multiple references that prices apply “if a licensed provider approves you” and that your price depends on your plan.
Check Telos Rx pricing and eligibility
2. Medications offered
TMates: The captured TMates evidence centers on clinically dosed compounded semaglutide and notes limited public detail on tirzepatide availability and no branded Ozempic, Wegovy, or Zepbound. Telos Rx: The Telos material explicitly offers both compounded semaglutide and compounded tirzepatide, describing tirzepatide as acting on GLP-1 plus GIP and listing separate price points for each.
3. Clinician access and review process
TMates: TMates claims 24/7 access to U.S.-based doctors in all 50 states and says this is actual physician availability, not just asynchronous messaging support. Telos Rx: Telos states medications are prescribed only “after review by a US-licensed provider” and that treatment is available only when a licensed clinician determines it is medically appropriate.
4. State coverage and shipping
TMates: The TMates evidence repeatedly notes licensed coverage in all 50 states and that they ship to most states with availability based on medical eligibility. Telos Rx: Telos cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change and recommends confirming eligibility, total cost and state availability before enrollment.
5. Regulatory status of compounded medications
Both providers include the regulatory qualifier that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. TMates uses that regulatory note in multiple captured lines. Telos Rx repeats that compounded semaglutide and tirzepatide are prescription only and are not FDA approved.
| Criteria | TMates | Telos Rx |
|---|---|---|
| Starting price | $199/month flat, same price at every dose | Semaglutide as low as $99/month; tirzepatide as low as $139/month, if a licensed provider approves you |
| Medications offered | Compounded semaglutide; limited public detail on tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Pricing model | Flat $199/month with no step-up fees | Variable “as low as” pricing; your price depends on your plan and approval |
| Clinician access | 24/7 U.S. doctor access, virtual check-ins included | Prescribed after review by a US-licensed provider; treatment available when clinician approves |
| State coverage & shipping | Licensed coverage in all 50 states; ships to most states, subject to medical eligibility | State coverage and pharmacy may change; confirm availability before enrollment |
| Regulatory note | Compounded medications are not FDA approved | Compounded medications are not FDA approved |
How the differences affect you
If you prioritize predictable cost at therapeutic doses and continuous physician availability, TMates’ flat $199/month and explicit 24/7 U.S. doctor access are the distinctive claims that support that choice. If you prioritize lower starting monthly price or want access to both semaglutide and tirzepatide options, Telos Rx offers semaglutide from $99/month and tirzepatide from $139/month, with both subject to clinician approval.
See Telos Rx medication options
Safety and eligibility reminders
Both sources emphasize that compounded medications are prescription-only and not FDA approved. TMates notes availability is based on medical eligibility and that patients should resume doses as scheduled without doubling up. Telos specifies that treatment is subject to clinician review and that individual results vary and are not guaranteed.
Join TMates and review clinician access
Conclusion: TMates vs Telos Rx
Primary keyword: TMates vs Telos Rx. Choose TMates if you want a predictable flat-rate semaglutide program with 24/7 U.S. doctor access and same price at every dose. Choose Telos Rx if you need lower starting pricing and want the option of compounded tirzepatide or semaglutide with final approval determined by a licensed provider.